Salubris Pharmaceuticals

Chinese pharmaceutical company

Shenzhen Salubris Pharmaceuticals (Chinese: 深圳信立泰药业; pinyin: Shēnzhèn Xìnlìtài Yàoyè; SZSE: 002294) is a Chinese pharmaceutical company.

Founded in November 1998 and based in Shenzhen, it has a market cap of US$4.4 billion, 3,121 employees and annual sales of $553 million as of 2019.[1]

Shenzhen Salubris is headed by the billionaire Ye Chenghai.[2]

## References

[edit]

1. ^ "Shenzhen Salubris Pharmaceuticals". Forbes. Retrieved 6 April 2019.
2. ^ "Ye Chenghai". Forbes. Retrieved 16 May 2015.

* v
* t
* e

Pharmaceutical companies of China

* CanSino Biologics
* CSPC Zhongrun
* China Nepstar
* Fosun Pharmaceutical
* Guangzhou Pharmaceuticals
* Guangyuyuan
* Guizhentang Pharmaceutical Company
* Harbin Pharmaceutical Group
* Hebei Yuxing Bio-Engineering Co. Ltd
* Huadong Medicine
* Jilin Aodong Medicine
* Lijun International Pharmaceutical (Holding) Co. Ltd.
* Kunming Pharmaceutical Corporation
* Nanjing Ange Pharmaceutical
* North China Pharmaceutical Group
* Salubris Pharmaceuticals
* Shanghai Pharmaceuticals Holding Co., Ltd.
* Shenzhen Kangtai Biological Products
* Shijiazhuang Pharma Group
* Sihuan Pharmaceutical
* Simcere Pharmaceutical
* China National Pharmaceutical Group
* Sinopharm Group
* Sinovac Biotech
* Tasly
* Tong Ren Tang
* Xiangxue Pharmaceutical
* Yangtze River Pharmaceutical Group
* Yunnan Baiyao Group
* WuXi AppTec

*[v]: View this template
*[t]: Discuss this template
*[e]: Edit this template